Conditions: Overactive Bladder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2012
Healthy volunteers: no

Brief summary:
This study is designed to confirm if 8mg of fesoterodine is more effective in reducing overactive bladder symptoms than 4mg of fesoterodine. In addition the study is designed to assess if the higher dose reduces the overall effect of overactive bladder on the subject's daily life more than the lower dose. The study also assesses the side effects and safety of the two doses.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: Fesoterodine 8mg intervention 2: Fesoterodine 4mg intervention 3: Placebo
Intervention descriptions: intervention 1: Oral, 1 tablet per day, 12 weeks duration, 8mg/day intervention 2: Oral, 1 tablet per day, 12 weeks duration, 4mg/day intervention 3: Oral, 1 tablet per day, 12 weeks duration

Protocol document: